avita medical research

AVITA Medical introduced the RECELL ® System to the U.S. in September 2018. As a team of healthcare professionals and volunteers doing clinical research studies in Tampa, Florida, we give you our highest admiration. No use of any AVITA trademark, trade name, or trade dress in this site may be made without the prior written authorization of AVITA, except to identify the product or services of the company.Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to AVITA, its subsidiaries or affiliates. AVITA Medical is a publicly listed, global regenerative medicine company that provides a novel approach to skin regeneration. Avita Medical is a clinical and commercial company developing and marketing a range of respiratory and regenerative products. It may be taken for granted often but clinical research is a vital part of healthcare These cookies are used to improve your website experience and provide more personalized services to you, both on this website and through other media. xThe Emergency Department (ED) wait times are approximate and provided for information purposes only. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. AVITA Medical is a regenerative medicine company focused on the development and commercialization of innovative therapies with the power to transform lives. For complete Important Safety Information, refer to AVITA Medical is a publicly listed, global regenerative medicine company that provides a novel approach to skin regeneration.

We're harnessing point-of-care regenerative medicine to unlock bold ways of restoring skin.We're harnessing point-of-care regenerative medicine to unlock bold ways of restoring skin.We're harnessing point-of-care regenerative medicine to unlock bold ways of restoring skin.We're harnessing point-of-care regenerative medicine to unlock bold ways of restoring skin.We’re elevating the standard of care for the treatment of skin restoration.We’re exploring the potential of this novel technology platform to harness the regenerative properties of a patient’s own skin across a number of dermatological indications. To find out more about the cookies we use, see our ©Copyright 2020 AVITA Medical. Browse Enrolling Studies 14829 North …

AVITA Medical’s proprietary technology has evidence for additional skin applications beyond treating burns, such as chronic and traumatic wounds, scar revision, and vitiligo.Unless otherwise specified, all product and service names appearing in this Internet site are trademarks owned by or licensed to AVITA, its subsidiaries or affiliates. Have you been seriously considering to participate in a clinical trial?

The Manager, Clinical Research will oversee the operational aspects of AVITA’s clinical trials while managing and developing the Clinical Research staff.

Excellence in Research Today Societal progress, especially in the health systems, relies on well-researched studies.

All Rights Reserved. Hedge Funds Watching Avita Medical Limited (RCEL) From Afar. This website stores cookies on your computer. As the first new PMA-approved treatment for burn care in more than 20 years, the RECELL ® System represents a major advancement over the current standard of care for burn patients, offering benefits in both clinical outcomes and cost savings. Our products provide innovative treatment solutions derived from the regenerative properties of a patient’s own skin. The researchers gather information, group the volunteers according to characteristics, and then compareStrictly speaking, clinical research is a branch of healthcare science wherein the main purpose is to determine the safety and effectiveness of certain medications, medical devices, diagnostic products, and treatment procedures and regimens that are intended for human use.

The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. All Rights Reserved.©Copyright 2020 AVITA Medical.

Participating in a clinical trial is truly a great contribution to the wider scope of the healthcare industry. Harnessing the regenerative properties of a patient’s own skin, AVITA Medical’s RECELL ® System was approved by the U.S. Food and Drug Administration (FDA) in September 2018.

The in-house Clinical Research Associate serves as a key resource for the Clinical Research Department managing AVITA’s clinical trials.